COMMUNIQUÉS West-GlobeNewswire

CymaBay Therapeutics Strengthens Management Team with Appointment of Paul Quinlan as General Counsel
04/12/2017
NEWARK, Calif., Dec. 04, 2017 (GLOBE NEWSWIRE) -- CymaBay Therapeutics, Inc. (NASDAQ: CBAY ), a clinical-stage biopharmaceutical company focused on developing therapies for liver and other chronic diseases with high [...]
VANC Pharmaceuticals Executes Share Purchase Agreement to Acquire HealthTab Inc.
04/12/2017
VANCOUVER, British Columbia, Dec. 04, 2017 (GLOBE NEWSWIRE) -- VANC Pharmaceuticals Inc. (“ VANC ” or the “ Company ”) (TSXV:VANC) (OTCQB:NUVPF) is pleased to announce that it has entered into a share purchase agreement [...]
CorVel Successfully Implements CareMC Edge
04/12/2017
IRVINE, Calif., Dec. 04, 2017 (GLOBE NEWSWIRE) -- CorVel Corporation (NASDAQ: CRVL ) announced today the successful implementation of their CareMC Edge data integration tool for the insurance carrier marketplace. [...]
The American Health Council Physician Board Welcomes Indrani Hightower, MD
04/12/2017
NEW YORK, Dec. 04, 2017 (GLOBE NEWSWIRE) -- The American Health Council is proud to recognize Indrani Sen Hightower, MD as an affiliate of its Physician Board. She has spent the last two years as a Neurologist at [...]
XBiotech Announces Publication of Phase 2 Data from Hidradenitis Suppurativa Phase 2 Study in The Journal of Investigative Dermatology
04/12/2017
AUSTIN, Texas, Dec. 04, 2017 (GLOBE NEWSWIRE) -- XBiotech Inc. (NASDAQ: XBIT ) announced today the publication of data from its randomized phase 2 study evaluating XBiotech’s True Human™ antibody, MABp1, as a treatment [...]
Emblem Corp. Provides Business Update for 2018
04/12/2017
TORONTO, Dec. 04, 2017 (GLOBE NEWSWIRE) -- Emblem Corp. ( “Emblem” or the “ Company ”) (TSXV:EMC), a vertically integrated cannabis company focused on research, development, production and distribution of cannabis [...]
Daré Bioscience, Inc. to Present at the LD Micro 10th Annual Main Event Conference
04/12/2017
SAN DIEGO, Dec. 04, 2017 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE ), a healthcare company committed to the development and commercialization of innovative products in women’s reproductive health, today [...]
Zogenix Announces New Positive Efficacy and Safety Data from Pivotal Phase 3 Clinical Trial of ZX008 in Dravet Syndrome
04/12/2017
ZX008 Patients More Likely to Achieve Clinically Meaningful Reduction in Seizure Frequency Compared to Those on Placebo Parents/Caregivers and Investigators Rated Patients Treated with ZX008 as Very Much Improved or [...]
Oncolix, Inc. Expands Board of Directors with New Appointment
04/12/2017
HOUSTON, Dec. 04, 2017 (GLOBE NEWSWIRE) -- Oncolix, Inc. (OTC PINK:ONCX) (the “Company”), a biotechnology company focused on gynecological cancers, announced the appointment of John W. Holaday, Ph.D., to the Company’s [...]
Cutera Announces Appointment of Sandra Gardiner as CFO
04/12/2017
BRISBANE, Calif., Dec. 04, 2017 (GLOBE NEWSWIRE) -- Cutera, Inc. (NASDAQ: CUTR ) (“Cutera” or the “Company”), a leading provider of laser and energy-based aesthetic systems for practitioners worldwide, announced the [...]
Ultragenyx and Kyowa Kirin Announce Positive 48-Week Data from Adult Phase 3 Study of Burosumab (KRN23) in X-Linked Hypophosphatemia
04/12/2017
NOVATO, Calif. and TOKYO and LONDON, Dec. 04, 2017 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE ), a biopharmaceutical company focused on the development of novel products for rare and ultra-rare [...]
ProMIS Neurosciences Announces Trading on OTCQB Venture Market
04/12/2017
TORONTO and CAMBRIDGE, Mass., Dec. 04, 2017 (GLOBE NEWSWIRE) -- ProMIS Neurosciences, Inc., a company focused on the discovery and development of precision treatments for neurodegenerative diseases, today announced that [...]
Summit Therapeutics plc : Notice of Third Quarter Results
04/12/2017
Summit Therapeutics plc ("Summit" or the "Company") SUMMIT THERAPEUTICS TO REPORT FINANCIAL RESULTS FOR THE THIRD QUARTER AND NINE MONTHS ENDED 31 OCTOBER 2017 ON 6 DECEMBER 2017 Oxford, UK, 4 December 2017 - Summit [...]
BeyondSpring’s Lead Asset, Plinabulin, Recognized as 2017 National Science and Technology Major Project in China
04/12/2017
NEW YORK, Dec. 04, 2017 (GLOBE NEWSWIRE) -- BeyondSpring Inc. (NASDAQ: BYSI ), a global clinical stage biopharmaceutical company focused on the development of innovative immuno-oncology cancer therapies, today announced [...]
AzurRx BioPharma to Present at the Biotech Showcase 2018 Conference (January 8th)
04/12/2017
BROOKLYN, N.Y., Dec. 04, 2017 (GLOBE NEWSWIRE) -- AzurRx BioPharma, Inc. (NASDAQ: AZRX ) (“AzurRx” or the “Company”), a company specializing in the development of non-systemic, recombinant therapies for gastrointestinal [...]
Resverlogix Closes Previously Announced $87 Million Private Placement with Shenzhen Hepalink
04/12/2017
CALGARY, Alberta, Dec. 04, 2017 (GLOBE NEWSWIRE) -- Resverlogix Corp. ("Resverlogix" or the "Company") (TSX: RVX ) announced today that it has closed its previously announced private placement of 60,416,667 equity units [...]
Summit Therapeutics to Report Financial Results for the Third Quarter and Nine Months Ended 31 October 2017 on 6 December 2017
04/12/2017
OXFORD, United Kingdom, Dec. 04, 2017 (GLOBE NEWSWIRE) -- Summit Therapeutics plc (AIM:SUMM) (NASDAQ: SMMT ), the drug discovery and development company advancing therapies for Duchenne muscular dystrophy and [...]
GW Pharmaceuticals plc Reports Fiscal Fourth Quarter 2017 and Year-End Financial Results and Operational Progress
04/12/2017
- Epidiolex ® (cannabidiol) NDA Submitted to FDA - - Conference call today at 7:30 a.m. EST - LONDON and CARLSBAD, Calif., Dec. 04, 2017 (GLOBE NEWSWIRE) -- GW Pharmaceuticals plc (Nasdaq: GWPH ) (GW, the Company or the [...]
Nabriva Therapeutics Announces Completion of Enrollment in LEAP 2, a Phase 3 Clinical Trial Evaluating Oral Lefamulin for the Treatment of Community-Acquired Bacterial Pneumonia in Adults
04/12/2017
DUBLIN, Ireland and KING OF PRUSSIA, Pa., Dec. 04, 2017 (GLOBE NEWSWIRE) -- Nabriva Therapeutics plc (NASDAQ: NBRV ), a clinical stage biopharmaceutical company engaged in the research and development of novel anti- [...]

Pages